Brenus Pharma
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
€11MSeries A
Role not disclosedS
Sambrinvest
sambrinvest.be ↗Activity from announced rounds
Activity in this selectionFrance · Oct 12, 2026 · Jan 1, 2026
Sambrinvest provides financing and company support in the Charleroi region, with activity across life sciences, digital businesses and industry.
A regional financing partner
Sambrinvest is a financial partner for businesses in the Charleroi region of Belgium. It supports entrepreneurs and small and medium-sized companies with financing adapted to their projects. Its work spans multiple sectors, including life sciences, technology and industrial businesses, and connects company funding with development of the regional business ecosystem.
Activity recorded by RoundOS
RoundOS records Sambrinvest participation in Brenus Pharma, Enodia Therapeutics and Novadip Biosciences. Those financings cover cancer immunotherapy, protein-degradation drug discovery and regenerative medicine. They are examples within the database’s current coverage, while Sambrinvest maintains a much broader company portfolio.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $36.7M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionEnodia Therapeutics
Develops small-molecule therapies for targeted protein degradation at the point of synthesis
€20.7MSeed
Role not disclosed